BA
XENT

BlackRock Advisors’s Intersect ENT, Inc XENT Stock Holding History

BlackRock Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$182K Sell
15,054
-6,183
-29% -$80K ﹤0.01% 2768
2016
Q3 		$336K Buy
21,237
+3,489
+20% +$52.5K ﹤0.01% 2385
2016
Q2 		$229K Buy
17,748
+9,396
+113% +$147K ﹤0.01% 2523
2016
Q1 		$159K Buy
8,352
+1,728
+26% +$31.3K ﹤0.01% 2675
2015
Q4 		$149K Sell
6,624
-1,514
-19% -$29.9K ﹤0.01% 2726
2015
Q3 		$190K Buy
8,138
+1,119
+16% +$30.9K ﹤0.01% 2756
2015
Q2 		$201K Buy
7,019
+4,305
+159% +$113K ﹤0.01% 2787
2015
Q1 		$70K Buy
2,714
+477
+21% +$10.9K ﹤0.01% 3164
2014
Q4 		$41K Hold
2,237
– – ﹤0.01% 3329
2014
Q3 		$35K Buy
+2,237
New +$33.7K ﹤0.01% 3358

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors's XENT Position: Q4 2016 in Review

BlackRock Advisors reduced its Intersect ENT, Inc (XENT) stake by 29% in Q4 2016, selling an estimated $80K and leaving 15,054 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

BlackRock Advisors first reported a position in XENT in Q3 2014 and has held it in 10 quarters since. The position peaked at $336K in Q3 2016. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

  • BlackRock Advisors held 15,054 shares of Intersect ENT, Inc worth $182K as of Q4 2016.
  • BlackRock Advisors sold 6,183 Intersect ENT, Inc shares in Q4 2016, an estimated $80K.
  • Intersect ENT, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2768 holding.
  • BlackRock Advisors first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Advisors's Intersect ENT, Inc position peaked at $336K in Q3 2016.
  • 104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.